H.Res. 242 · 116th Congress
Affirming the importance of the Orphan Drug Act, celebrating the over 750 new orphan therapies approved since its creation, and recognizing the need to continue supporting research and development for rare diseases.
- Stage
- In committee
- Sponsor
- G.K. Butterfield
- Introduced
- 2019-03-18
- Latest action
- 2019-03-19 · Referred to the Subcommittee on Health.
Subjects
Health care costs and insurance
Health care coverage and access
Congressional tributes
Health
Health promotion and preventive care
Health care quality
Medical research
Drug therapy
Research and development
Prescription drugs
Drug safety, medical device, and laboratory regulation